Ultragenyx Pharmaceutical | RARE - Action





Action Changement Date
Acadia Pharmaceuticals USD 108.67M 77.1M 2026-06
Agios Pharmaceuticals USD 35.75M 665K 2026-06
Alnylam Pharmaceuticals USD 97.11M 103.04M 2026-06
BioCryst Pharmaceuticals USD 6.06M 71K 2026-06
BioMarin Pharmaceutical USD 1.78B 509.3M 2026-06
Insmed USD 142.38M 9.48M 2026-06
Ionis Pharmaceuticals USD 50.83M 45.28M 2026-06
Karyopharm Therapeutics USD 4.04M 72K 2025-12
Kyowa Hakko Kirin JPY 67.44B 5.42B 2025-12
MacroGenics USD 9.5M 1.59M 2026-03
Moderna USD 280M 134M 2026-06
Neurocrine Biosciences USD 104.2M 39.7M 2026-06
PTC Therapeutics USD 91.35M 15.79M 2026-06
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.08B 19.3M 2026-06
Sarepta Therapeutics USD 904.27M 96.84M 2026-06
Ultragenyx Pharmaceutical USD 59M 4M 2026-06
Vertex Pharmaceuticals USD 1.77B 1.6M 2026-06